Turkish Journal of Surgery

Turkish Journal of Surgery

ISSN: 2564-6850
e-ISSN: 2564-7032

 

Süleyman Çetinkünar1, Hasan Erdem1, Recep Aktimur2, Mehmet Aziret3, Sabri Özdaş4, Banu Yürekli5, Fahri Yetişir6

1Clinic of General Surgery, Adana Numune Training and Research Hospital, Adana, Turkey
2Clinic of General Surgery, Samsun Training and Research Hospital, Samsun, Turkey
3Clinic of General Surgery, Kars State Hospital, Kars, Turkey
4Clinic of General Surgery, Adıyaman Training and Research Hospital, Adıyaman, Turkey
5Department of Endocrinology, Ege University Faculty of Medicine, İzmir, Turkey
6Clinic of General Surgery, Atatürk Training and Research Hospital, Ankara, Turkey

Abstract

Objective: Bariatric surgery in multimodal management modalities is a more effective method to treat morbid obesity and obesity-related comorbidities compared with nonsurgical treatments. Laparoscopic sleeve gastrectomy (LSG) was initially performed as the first stage of biliopancreatic diversion with duodenal switch in the super-obese population. In the past few years, however, LSG has been performed as a definitive procedure because of its promising early and midterm results. The aim of this study is to evaluate the efficacy of our initial LSG series of 73 patients on excess weight loss (EWL) and resolution of obesity-related comorbidities in short-term follow-up.
Material and Methods: From March 2013 to May 2014, 78 morbid obese patients with an average body mass index (BMI) of 46.3 kg/m2 underwent LSG. There is a 9-month follow-up period on average. Five patients were excluded from the study, because they could not be contacted. Comorbidities, preintervention BMI, glucose, HbA1c, and lipid profiles were recorded at 1, 6, and 12 months postintervention.
Results: After the surgery, the percent EWL (%EWL) was 58%. The mean serum glucose level, HbA1c level, LDL-cholesterol level, triglyceride level, insulin, and insulin resistance decreased significantly and the mean HDL-cholesterol level increased.
Conclusion: For the resolution of comorbidities, LSG may be used as an effective bariatric and metabolic surgery.

Keywords: Sleeve gastrectomy, bariatric surgery, morbid obesity


 

Ethics Committee Approval

Ethics committee approval was received for this study from the ethics committee of Adana Numune Training and Research Hospital.

Peer Review

Externally peer-reviewed.

Author Contributions

Concept - S.Ç., H.E.; Design - S.Ç., H.E., F.Y.; Supervision - S.Ç., H.E.; Funding - S.Ç., R.A.; Materials - M.A., S.Ö.; Data Collection and/or Processing - B.Y., R.A., S.Ö., M.A.; Analysis and/or Interpretation - B.Y., R.A., F.Y.; Literature Review - S.Ö., M.A.; Writer - S.Ç.; Critical Review - F.Y., B.Y.

Conflict of Interest

No conflict of interest was declared by the authors.

Financial Disclosure

The authors declared that this study has received no financial support.